Skip to main content
SpringerLink
Log in

Pathogenesis of diabetic nephropathy, advanced glcation and new therapy

  • Published:
Medizinische Klinik Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. The Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. New Engl. J. Med. 329 (1993), 977–986.

    Article  Google Scholar 

  2. Bucala, R., H. Vlassara, A. Cerami: Advanced glycosylation endproducts. In: Harding, J. J., M. J. C. Crabbe (eds.): Post translational modification of proteins. CRC Press Inc., Boca Raton, FL 1992, vol. 2, p. 53–79.

    Google Scholar 

  3. Vlassara, H., R. Bucala, L. Striker: Pathogenic effects of advanced glycosylation: biochemical, biologic, and clinical implications for diabetes and aging. J. Lab. Invest. 70 (1994), 138–151.

    CAS  Google Scholar 

  4. Dyer, D. G., J. A. Blackledge, B. M. Katz, C. J. Hull, H. D. Adkisson, S. R. Thorpe, T. J. Lyons, J. W. Baynes: The Maillard reaction in vivo. Z. Ernährungswiss. 30 (1991), 29–45.

    Article  PubMed  CAS  Google Scholar 

  5. Bailey, A. J., T. J. Sims, N. C. Avery, C. A. Miles: Chemistry of collagen cross-links — glucose-mediated covalent cross-linking of type-IV collagen in lens capsules. Biochem. J. 296 (1993), 489–496.

    PubMed  CAS  Google Scholar 

  6. Dyer, D. G., J. A. Blackledge, S. R. Thorpe, J. W. Baynes: Formation of pentosidine during nonenzymatic browning of proteins by glucose — identification of glucose and other carbohydrates as possible precursors of pentosidine in vivo. J. Biol. Chem. 266 (1991), 11654–11660.

    PubMed  CAS  Google Scholar 

  7. Fu, M. X., K. J. Well-Knecht, J. A. Blackledge, T. J. Lyons, S. R. Thorpe, J. W. Baynes: Glycation, glycoxidation, and cross-linking of collagen by glucose: kinetics, mechanisms, and inhibition of late stages of the Maillard reaction. Diabetes 43 (1994), 676–683.

    Article  PubMed  CAS  Google Scholar 

  8. Vlassara, H.: Non-enzymatic glycosylation. Diabetes Ann. 18 (1991), 371–389.

    Google Scholar 

  9. Nakamura, K., T. Hasegawa, Y. Fukunaga, K. Lenaga: Crosslines A and B as candidates for the fluorophores in age- and diabetes-related cross-linked proteins, and their diacetates produced by Maillard reaction ofα-N-acetyl-L-lysine with D-glucose. J. chem. Soc. chem. Commun. 14 (1992), 992–994.

    Article  Google Scholar 

  10. Nakayama, H., S. Taneda, S. Kuwajima, S. Aoki, Y. Kuroda, K. Misawa, S. Nakagawa: Production and characterization of antibodies to advanced glycation products on proteins. Biochem. biophys. Res. Comm. 162 (1989), 740–745.

    Article  PubMed  CAS  Google Scholar 

  11. Horiuchi, S., N. Araki, Y. Morino: Immunochemical approach to characterize advanced glycation endproducts of the Maillard Reaction. J. biol. Chem. 266 (1991), 7329–7332.

    PubMed  CAS  Google Scholar 

  12. Makita, Z., H. Vlassara, A. Cerami, R. Bucala: Immunochemical detection of advanced glycosylation endproducts in vivo. J. biol. Chem. 267 (1992), 5133–5138.

    PubMed  CAS  Google Scholar 

  13. Brownlee, M., H. Vlassara, A. Kooney, P. Ulrich, A. Cerami: Aminoguanidine prevents diabetes-induced arterial wall protein cross-linking. Science 232 (1986), 1629–1632.

    Article  PubMed  CAS  Google Scholar 

  14. Bucala, R., K. J. Tracey, A. Cerami: Advanced glycosylation products quench nitric oxide and mediate defective endothelium-dependent vasodilatation in experimental diabetes. J. clin. Invest. 87 (1991), 432–438.

    Article  PubMed  CAS  Google Scholar 

  15. De Tejada, I. S., I. Goldstein, K. Azadzoi, R. J. Krane, R. J. R. Cohen: Impaired neurogenic and endothelium-mediated relaxation of penile smooth muscle in diabetic men with impotence. New Engl. J. Med. 320 (1989), 1025–1030.

    Google Scholar 

  16. McVeigh, G. E., G. M. Brennan, G. D. Johnston, B. J. McDermott, L. T. McGrath, W. R. Henry, J. W. Andrews, J. R. Hayes: Impaired endothelium-dependent and independent vasodilation in patients with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 35 (1992), 771–776.

    PubMed  CAS  Google Scholar 

  17. Gascho, J. A., C. Fanelli, R. Zelis: Aging reduces venous distensibility and the venodilatory response to nitroglycerin in normal subjects. Am. J. Cardiol. 63 (1989), 1267–1270.

    Article  PubMed  CAS  Google Scholar 

  18. Vlassara, H., H. Fuh, Z. Makita, S. Krungkrai, A. Cerami, R. Bucala: Exogenous advanced glycosylation endproducts induce complex vascular dysfunction in normal animals; a model for diabetic and aging complications. Proc. nat. Acad. Sci. (Wash.) 89 (1992), 12043–12047.

    Article  CAS  Google Scholar 

  19. Hogan, M., A. Cerami, R. Bucala: Advanced glycosylation endproducts block the antiproliferative effect of nitric oxide. J. clin. Invest. 90 (1992), 1110–1115.

    Article  PubMed  CAS  Google Scholar 

  20. Bucala, R., Z. Makita, T. Koschinsky, A. Cerami, H. Vlassara: Lipid advanced glycosylation. Pathway for lipid oxidation in vivo. Proc. nat. Acad. Sci. (Wash.) 90 (1993), 6434–6438.

    Article  CAS  Google Scholar 

  21. Bucala, R., Z. Makita, G. Vega, S. Grundy, T. Koschinsky, A. Cerami, H. Vlassara: Modification of LDL by advanced glycosylation endproducts contributes to the dyslipidemia of diabetes and renal insufficiency. Proc. nat. Acad. Sci. (Wash.) 91 (1994), 9441–9445.

    Article  CAS  Google Scholar 

  22. Nicholls, K., T. E. Mandel: Advanced glycosylation endproducts in experimental murine diabetic nephropathy. Effect of islet isografting and of aminoguanidine. J. Lab. Invest. 60 (1989), 486–491.

    CAS  Google Scholar 

  23. Ellis, E. N., B. H. Good: Prevention of glomerular basement membrane thickening by aminoguanidine in experimental diabetes mellitus. Metabolism 40 (1991), 1016–1019.

    Article  PubMed  CAS  Google Scholar 

  24. Soulis-Liparota, T., M. Cooper, D. Papazoglou, B. Clarke, G. Jerums: Retardation by aminoguanidine of development of albuminuria, mesangial expansion, and tissue fluorescence in streptozotocin-induced diabetic rat. Diabetes 40 (1991), 1328–1334.

    Article  PubMed  CAS  Google Scholar 

  25. Edelstein, D., M. Brownlee: Aminoguanidine ameliorates albuminuria in diabetic hypertensive rats. Diabetologia 35 (1992), 96–97.

    Article  PubMed  CAS  Google Scholar 

  26. Itakura, M., H. Yoshikawa, C. Bannai, M. Kato, K. Kunika, Y. Kawakami, T. Tamaoka, K. Yamashita: Aminoguanidine decreases urinary albumin and high-molecular-weight proteins in diabetic rats. Life Sci. 49 (1991), 889–897.

    Article  PubMed  CAS  Google Scholar 

  27. Cho, H. K., H. Kozu, G. A. Peyman, G. J. Parry, B. Khoobehi: The effect of aminoguanidine on the blood-retinal barrier in streptozotocin-induced diabetic rats. Ophthal. Surg. 22 (1991), 44–47.

    CAS  Google Scholar 

  28. Hammes, H. P., S. Martin, K. Federlin, K. Geisen, M. Brownlee: Aminoguanidine treatment inhibits the development of experimental diabetic retinopathy. Proc. nat. Acad. Sci. (Wash.) 88 (1991), 11555–11558.

    Article  CAS  Google Scholar 

  29. Hammes, H.-P., M. Brownlee, D. Edelstein, M. Saleck, S. Martin, K. Federlin: Aminoguanidine inhibits the development of accelerated diabetic retinopathy in the spontaneous hypertensive rat. Diabetologia 37 (1994), 32–35.

    Article  PubMed  CAS  Google Scholar 

  30. Huijberts, M. S. P., B. H. R. Wolffenbuttel, H. A. J. Struijker-Boudier, F. R. L. Crijns: Aminoguanidine treatment increases elasticity and decreases fluid filtration of large arteries from diabetic rats. J. clin. Invest. 92 (1993), 1407–1411.

    Article  PubMed  CAS  Google Scholar 

  31. Huijberts, M. S. P., B. H. R. Wolffenbuttel, F. R. L. Crijns, A. C. Nieuwenhuijzen Kruseman, M. H. A. Bemelmans, H. A. J. Struijker Boudier: Aminoguanidine reduces regional albumin clearance but not urinary albumin excretion in streptozotocin-diabetic rats. Diabetologia 37 (1994), 10–14.

    Article  PubMed  CAS  Google Scholar 

  32. Kihara, J., J. D. Schmelzer, J. F. Podusio, G. L. Curran, K. K. Nickander, P. A. Low: Aminoguanidine effects on nerve blood flow, vascular permeability, electrophysiology, and oxygen free radicals. Proc. nat. Acad. Sci. (Wash.) 88 (1991), 6107–6111.

    Article  CAS  Google Scholar 

  33. Yagihashi, S., M. Kamijo, M. Baba, N. Yagihashi, K. Nagai: Effect of aminoguanidine on functional and structural abnormalities in peripheral nerve of STZ-induced diabetic rats. Diabetes 41 (1992), 47–52.

    Article  PubMed  CAS  Google Scholar 

  34. Cameron, N. E., M. A. Cotter, K. Dines, A. Love: Effects of aminoguanidine on peripheral nerve function and polyol pathway metabolites in streptozotocin-diabetic rats. Diabetologia 35 (1992), 946–950.

    Article  PubMed  CAS  Google Scholar 

  35. Odetti, P. R., A. Borgoglio, A. De Pascale, R. Rolandi, L. Adezati: Prevention of diabetes-increased aging effect on rat collagen-linked fluorescence by aminoguanidine and rutin. Diabetes 39 (1990), 796–801.

    Article  PubMed  CAS  Google Scholar 

  36. Oxlund, H., T. T. Andreassen: Aminoguanidine treatment reduces the increase in collagen stability of rats with experimental diabetes mellitus. Diabetologia 35 (1992), 75–78.

    Article  Google Scholar 

  37. Makita, Z., H. Vlassara, E. Rayfield, K. Cartwright, E. Friedman, R. Rodby, A. Cerami, R. Bucala: Hemoglobin-AGE: A circulating marker of advanced glycosylation. Science 258 (1992), 651–653.

    Article  PubMed  CAS  Google Scholar 

  38. Vlassara, H., M. Brownlee, A. Cerami: High-affinity receptor-mediated uptake and degradation of glucose-modified proteins: A potential mechanism for the removal of senescent macromolecules. Proc. nat. Acad. Sci. (Wash.) 82 (1985), 5588–5592.

    Article  CAS  Google Scholar 

  39. Vlassara, H., M. Brownlee, A. Cerami: Novel macrophage receptor for glucose-modified proteins is distinct from previously described scavenger receptors. J. exp. Med. 164 (1986), 1301–1309.

    Article  PubMed  CAS  Google Scholar 

  40. Yang, Z., Z. Makita, Y. Horii, S. Brunelle, A. Cerami, P. Sehajpal, M. Suthanthiran, H. Vlassara: Two novel rat liver membrane proteins that bind advanced glycosylation endproducts: Relationship to macrophage receptor for glucose-modified proteins. J. exp. Med. 174 (1991), 515–524.

    Article  PubMed  CAS  Google Scholar 

  41. Kirstein, M., J. Brett, S. Radoff, D. Stern, H. Vlassara: Advanced Glycosylation Endproducts selectively induce monocyte migration across intact endothelial cell monolayers, and elaboration of growth factors: Role in aging and diabetic vasculopathy. Proc. nat. Acad. Sci. (Wash.) 87 (1990), 9010–9014.

    Article  CAS  Google Scholar 

  42. Vlassara, H., M. Brownlee, K. R. Manogue, A. Pasagian, C. A. Dinarello: Cachetin/TNF and IL-1 induced by glucose-modified proteins: role in normal tissue remodeling. Science 240 (1988), 1546–1548.

    Article  PubMed  CAS  Google Scholar 

  43. Imani, F., Y. Horii, M. Suthanthiran, E. Y. Skolnik, Z. Makita, V. Sharma, P. Sehajpal, H. Vlassara: Advanced glycosylation endproduct-specific receptors on human and rat T-lymphocytes mediate synthesis of interferon-γ, role in tissue remodeling. J. exp. Med. 178 (1993), 2165–2172.

    Article  PubMed  CAS  Google Scholar 

  44. Libby, P., G. K. Hansson: Involvement of the immune system in human atherogenesis: Current knowledge and unanswered questions. J. Lab. Invest. 64 (1991), 5–15.

    CAS  Google Scholar 

  45. Esposito, C., D. Stern, H. Gerlach, H. Vlassara: Endothelial receptor-mediated binding of glucose-modified albumin is associated with increased monolayer permeability and modulation of cell surface coagulant properties. J. exp. Med. 170 (1989), 1387–1407.

    Article  PubMed  CAS  Google Scholar 

  46. Schmidt, A. M., M. Vianna, M. Gerlach, J. Brett, J. Ryan, J. Kao: Isolation and characterization of two binding proteins for advanced glycosylation end products from bovine lung which are present on the endothelial cell surface. J. biol. Chem. 256, 21 (1992), 14987–14997.

    Google Scholar 

  47. Neeper, M., A. M. Schmidt, J. Brett, S. D. Yan, F. Wang, Y. C. E. Pan, et al.: Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins. J. biol. Chem. 267 (1992), 14998–15004.

    PubMed  CAS  Google Scholar 

  48. Brett, J., A. M. Schmidt, S. D. Yan, Y. S. Zou, E. Weidman, D. Pinsky, R. Nowygrod, M. Neeper, C. Przysiecki, A. Shaw, A. Migheli, D. Stern: Survey of the distribution of a newly characterized receptor for advanced glycation endproducts in tissues. Amer. J. Path. 143 (1993), 1699–1712.

    PubMed  CAS  Google Scholar 

  49. Imani, F., D. Wojciechowicz, M. Creager, J. Greenidge, A. Cerami, H. Vlassara: Serum Mac-2 or carbohydrate binding protein-35 (CBP) binds glycated proteins and is elevated in diabetic sera. Faseb. J. 8 (1994), A1385.

  50. Skolnik, E. Y., Z. Yang, Z. Makita, S. Radoff, M. Kirstein, H. Vlassara: Human and rat mesangial cell receptors for glucose-modified proteins: Potential role in kidney tissue remodelling and diabetic nephropathy. J. exp. Med. 174 (1991), 931–939.

    Article  PubMed  CAS  Google Scholar 

  51. Doi, T., H. Vlassara, M. Kirstein, Y. Yamada, G. E. Striker, L. J. Striker: Receptor-specific increased mesangial cell extracellular matrix production is mediated by PDGF. Proc. nat. Acad. Sci. (Wash.) 89 (1992), 2873–2877.

    Article  CAS  Google Scholar 

  52. United States Renal Data System, USRDS 1992 Annual Data Report: The National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Disease. Bethesda, Maryland, August 1992.

  53. Yang, C. W., H. Vlassara, E. P. Peten, C. J. He, G. E. Striker, L. J. Striker: Advanced glycosylation endproducts upregulate gene expression found in diabetic glomerular disease. Proc. nat. Acad. Sci. (Wash.) 91 (1994), 9436–9440.

    Article  CAS  Google Scholar 

  54. Miyata, T., O. Oda, R. Inagi, Y. Iida, N. Araki, N. Yamada, S. Horiuchi, N. Taniguchi, K. Maeda, T. Kinoshita: β2-Microglobulin modified with advanced glycation end products is a major component of hemodialysis-associate amyloidosis. J. clin. Invest. 92 (1993), 1243–1252.

    Article  PubMed  CAS  Google Scholar 

  55. Vlassara, H., L. J. Striker, S. Teichberg, H. Fuh, Y. M. Li, M. Steffes: Advanced glycosylation endproducts induce glomerular sclerosis and albuminuria in normal rats. Proc. nat. Acad. Sci. (Wash.) 91 (1994), 11704–11708.

    Article  CAS  Google Scholar 

  56. Makita, Z., S. Radoff, E. J. Rayfield, Z. Yang, E. Skolnik, E. A. Friedman, A. Cerami, H. Vlassara: Advanced glycosylation endproducts in patients with diabetic nephropathy. New Engl. J. Med. 325 (1991), 836–842.

    Article  PubMed  CAS  Google Scholar 

  57. Makita, Z., R. Bucala, E. J. Rayfield, E. A. Friedman, A. M. Kaufman, S. M. Korbet, R. H. Barth, J. A. Winston, H. Fuh, K. R. Manogue, A. Cerami, H. Vlassara: Reactive glycosylation endproducts in diabetic uraemia & treatment of renal failure. Lancet 343 (1994), 1519–1522.

    Article  PubMed  CAS  Google Scholar 

  58. Miyata, T., R. Inagi, Y. Iida, M. Sato, N. Yamada, O. Oda, K. Maeda, H. Seo: Involvement of β2-microglobulin modified with advanced glycation endproducts in the pathogenesis of hemodialysis-associated amyloidosis. J. clin. Invest. 93 (1994), 521–527.

    Article  PubMed  CAS  Google Scholar 

  59. Koschinsky, T., C. He, T. Mitsuhashi, R. Bucala, C. Liu, H. Vlassara: Reactive advanced glycation endproducts (AGEs) from food: A new risk for diabetic complications. Diabetes 45, Suppl. 2 (1996), 127A.

    Google Scholar 

  60. Koschinsky, T., C. He, T. Mitsuhashi, R. Bucala, C. Liu, H. Vlassara: Orally absorbed reactive glycation products — A new risk factor in diabetic nephropathy. (1996) (submitted).

Download references

Author information

Authors and Affiliations

  1. Laboratory on Diabetes and Aging, The Picower Institute for Medical Research, 11030, Manhasset, NY, USA

    Helen Vlassara MD

Authors
  1. Helen Vlassara MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Vlassara, H. Pathogenesis of diabetic nephropathy, advanced glcation and new therapy. Med. Klin. 92 (Suppl 1), 29–34 (1997). https://doi.org/10.1007/BF03041807

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03041807

Keywords

Search

Navigation